Dr. Treise Nicole Tomlinson-Chesnut, MD

Dr. Tomlinson-Chesnut practices at Prestige Medical Associates, Inc. in Newbury Park, California.

Dr. Tomlinson-Chesnut's NPI, 1710970884, was assigned on August 24, 2005. Dr. Tomlinson-Chesnut graduated from David Geffen School of Medicine at UCLA in 1999. Dr. Tomlinson-Chesnut holds California license A75087.

Dr. Tomlinson-Chesnut's primary practice is Prestige Medical Associates, Inc., at 1000 Newbury Rd, Newbury Park, CA 91320 in Ventura County. The practice phone is (805) 214-3122.

Dr. Tomlinson-Chesnut's primary practice is Prestige Medical Associates, Inc. in Newbury Park, California. Dr. Tomlinson-Chesnut is also affiliated with Dignity Health - Northridge Hospital Medical Center. The medical group on file is Prestige Medical Associates. Dmand AI also links Dr. Tomlinson-Chesnut to 2 more hospitals, 1 community health center and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tomlinson-Chesnut practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tomlinson-Chesnut's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tomlinson-Chesnut is board certified in internal medicine by the American Board of Internal Medicine. Dr. Tomlinson-Chesnut is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, aneurysm, ankle or foot injury, aortic atherosclerois, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Tomlinson-Chesnut treats.

CMS data shows 1,965 Medicare services from Dr. Tomlinson-Chesnut across 22 procedure codes in 2024, for 262 Medicare patients. Medicare paid $129,954 for them. Every service was in an office.

CMS counts 262 Medicare patients who saw Dr. Tomlinson-Chesnut in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tomlinson-Chesnut's median patient age at 67, with 67% women.

In 2024, Dr. Tomlinson-Chesnut wrote 4,721 Medicare Part D claims for 344 patients. 85% of them were for generic drugs. CMS names the drug for 4,107 of them, across 87 drugs with 11 or more claims each, at $422,965 in total drug cost. In 2023, CMS named 4,157 claims across 91 drugs.

Dr. Tomlinson-Chesnut accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tomlinson-Chesnut as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,551 general payments to Dr. Tomlinson-Chesnut from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $3,307.

Dmand AI lists 1 award for Dr. Tomlinson-Chesnut, most recently CMS Stage 1 EHR in 2013.

Dr. Tomlinson-Chesnut graduated from David Geffen School of Medicine at UCLA in 1999.

Dr. Tomlinson-Chesnut is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.